GB866681A - N-substituted piperidines - Google Patents

N-substituted piperidines

Info

Publication number
GB866681A
GB866681A GB1655158A GB1655158A GB866681A GB 866681 A GB866681 A GB 866681A GB 1655158 A GB1655158 A GB 1655158A GB 1655158 A GB1655158 A GB 1655158A GB 866681 A GB866681 A GB 866681A
Authority
GB
United Kingdom
Prior art keywords
hydrogen atom
group
represent
methyl
tetramethylpiperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1655158A
Inventor
Leslie Bretherick
William Robert Wragg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
May and Baker Ltd
Original Assignee
May and Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May and Baker Ltd filed Critical May and Baker Ltd
Priority to GB1655158A priority Critical patent/GB866681A/en
Publication of GB866681A publication Critical patent/GB866681A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/28Nitrogen atoms
    • C07D295/30Nitrogen atoms non-acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/98Nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

The invention comprises compounds of the general formula: <FORM:0866681/IV (b)/1> and their acid addition salts wherein R1 represents a hydrogen atom or a methyl or ethyl group, and R11 represents a hydrogen atom or R1 and R11 together represent a methylene, ethylidene or allylidene group, R2 represents a hydrogen atom or a methyl group, R41 represents a hydrogen atom or a C1-3 alkyl group and R3 and R4 each represent a hydrogen atom or together represent a single bond and the preparation thereof, wherein R1 and R11 represent hydrogen atoms, by reducing a compound of the general formula: <FORM:0866681/IV (b)/2> or by reacting a compound of the general formula: <FORM:0866681/IV (b)/3> with hydroxylamine-O-sulphonic acid; wherein R1 and R1 together represent a methylene, ethylidene or allylidene group, by reacting a compound of (I) wherein R1 and R11 both represent hydrogen atoms with an aldehyde R5CHO wherein R5 represents a hydrogen atom or a methyl or a vinyl group, or a derivative thereof such as an acetal, thioacetal, diacyl derivative or a bisulphite addition compound; and wherein R1 represents a methyl or ethyl group and R11 represents a hydrogen atom, by alkylating a compound (I) where in R1 and R11 are hydrogen atoms or by reducing a compound of the general formula: <FORM:0866681/IV (b)/4> The first Provisional Specification relates to compounds (I) wherein R1 and R11 additionally both represent lower alkyl groups and to quaternary ammonium salts of the bases in general. 1-Nitroso-2,2,6,6- tetramethyl-1,2,5,6- tetrahydropyridine is prepared from sodium nitrite and 2,2,6,6-tetramethyl-1,2,5,6-tetrahydropyridine. Similarly are prepared 1-nitroso-2,2,6-trimethylpiperidine and 1-nitroso-2,2,4,6,6-pentamethyl-1,2,5,6-tetrahydropyridine. 2,2,4,5,6- Pentamethyl-1,2,5,6- tetrahydropyridine hydriodide is prepared by reacting methyl magnesium iodide with 2,2,6,6-tetramethylpiperid-4-one and heating the hydriodide of the 2,2,4,6,6-pentamethylpiperidin-4-ol so formed. 1-Formylamino-2,2,6,6- tetramethylpiperidine is prepared from formic acid and 1-amino-2,2, 6,6-tetramethylpiperidine.ALSO:Pharmaceutical compositions comprise a pharmaceutical carrier together with compounds of the general formula <FORM:0866681/VI/1> or their acid addition salts wherein R1 represents a hydrogen atom, a methyl or an ethyl group and R11 represents a hydrogen atom or R1 and R11 together represent a methylene, ethylidene or allylidene group, R2 represents a hydrogen atom or a methyl group, R14 represents a hydrogen atom or a C1-3 alkyl group and R3 and R4 represent a hydrogen atom or together represent a single bond. Acid addition salts include hydrohalides, phosphates, nitrates, sulphates, maleates, fumarates, citrates, tartrates, methanesulphonates and ethane disulphonates. Compositions are suitable for oral or parenteral administration and are in the form of tablets, pills, dispersable powders, granules, emulsions, suspensions, syrups and elixirs. Examples are given of tablets containing 1 - amino - 2,2,6,6 - tetramethylpiperidine hydrogen tartrate and 1-methyleneamino-2,2,6,6 - tetramethylpiperidine hydrogen tartrate and injectable aqueous solutions containing 1 - amino - 2,2,6,6 - tetramethylpiperidine and 1 - methylamino - 2,2,6,6 - tetramethylpiperidine hydrochlorides.
GB1655158A 1958-05-22 1958-05-22 N-substituted piperidines Expired GB866681A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1655158A GB866681A (en) 1958-05-22 1958-05-22 N-substituted piperidines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1655158A GB866681A (en) 1958-05-22 1958-05-22 N-substituted piperidines

Publications (1)

Publication Number Publication Date
GB866681A true GB866681A (en) 1961-04-26

Family

ID=10079357

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1655158A Expired GB866681A (en) 1958-05-22 1958-05-22 N-substituted piperidines

Country Status (1)

Country Link
GB (1) GB866681A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003028703A2 (en) * 2001-09-28 2003-04-10 Mcneil-Ppc, Inc. Immediate release tablet
WO2006115456A1 (en) * 2005-04-26 2006-11-02 Cambrex Karlskoga Ab Synthesis of 1-aminopiperidine
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
WO2010142810A1 (en) * 2009-06-12 2010-12-16 Centre National De La Recherche Scientifique (Cnrs) Synthesis of hydrazines from hydroxylamine-o-sulphonic acid
US7968120B2 (en) 2001-09-28 2011-06-28 Mcneil-Ppc, Inc. Modified release dosage forms
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US8673190B2 (en) 2001-09-28 2014-03-18 Mcneil-Ppc, Inc. Method for manufacturing dosage forms

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003028703A2 (en) * 2001-09-28 2003-04-10 Mcneil-Ppc, Inc. Immediate release tablet
WO2003028703A3 (en) * 2001-09-28 2003-07-10 Mcneil Ppc Inc Immediate release tablet
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7968120B2 (en) 2001-09-28 2011-06-28 Mcneil-Ppc, Inc. Modified release dosage forms
US7972624B2 (en) 2001-09-28 2011-07-05 Shun-Por Li Method of manufacturing modified release dosage forms
US8545887B2 (en) 2001-09-28 2013-10-01 Mcneil-Ppc, Inc. Modified release dosage forms
US8673190B2 (en) 2001-09-28 2014-03-18 Mcneil-Ppc, Inc. Method for manufacturing dosage forms
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
WO2006115456A1 (en) * 2005-04-26 2006-11-02 Cambrex Karlskoga Ab Synthesis of 1-aminopiperidine
WO2010142810A1 (en) * 2009-06-12 2010-12-16 Centre National De La Recherche Scientifique (Cnrs) Synthesis of hydrazines from hydroxylamine-o-sulphonic acid
FR2946651A1 (en) * 2009-06-12 2010-12-17 Centre Nat Rech Scient SYNTHESIS OF HYDRAZINES FROM HYDROXYLAMINE-O-SULFONIC ACID.

Similar Documents

Publication Publication Date Title
US3341538A (en) Certain 2, 6-methano-3-benzazocines
GB1047935A (en) Substituted piperazines and preparation thereof
ES318143A1 (en) Perhydro-1,2,4-thiadiazinedioxides-(1,1) and their preparation
GB1069563A (en) Adamantane and tricyclo[4,3,1,1]undecane derivatives
GB959994A (en) Basically substituted compounds and a process for their production
GB866681A (en) N-substituted piperidines
US3910928A (en) 3-(Cyanimino)-propionitriles
US3935227A (en) 2-[(Substituted-piperidinyl or tetrahydropyridinyl)alkyl]-1H-benz[de]isoquinoline-1,3(2H)-diones
US3657257A (en) 3-aryl-8-carbamoyl nortropanes
US3452026A (en) Substituted 1,2,3,4-tetrahydroquinolines
GB834290A (en) Substituted piperidines
GB964143A (en) Substituted quinolines
US3890323A (en) Phenylketone derivatives
US3498992A (en) Substituted 1,2,3,6-tetrahydro-4-pyridine acetic acid amides
GB1120186A (en) Cyclohexene amino acid derivatives and process for their preparation
GB1113754A (en) Dibenzocycloheptatriene derivatives and their preparation
US3118904A (en) Amidoximo alkyl
GB1325061A (en) Process for the production of azines
US3625948A (en) Process for the preparation of hexahydromethanobenzazocines
US3310566A (en) Substituted 4-piperidino-butyrophenone oximes
GB1027746A (en) 17-amino-androstane and -androstene derivatives
US3052684A (en) 4-aryl-4-alkanoyloxy-n-cyano substituted piperidines
GB850483A (en) Improvements in or relating to pyrimidine derivatives
GB1045811A (en) Dibenzocycloheptenylamines
IE34441L (en) Dibenzazepine derivatives